IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
IPSEN

PRESS RELEASE

published on 03/12/2025 at 07:28, 1 year 6 months ago

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
Ipsen appoints Olivia Brown as EVP, Global Head of Neurotoxins, leading strategic growth in therapeutic and aesthetic neurotoxins market. Olivia brings 20 years of pharmaceutical and aesthetics leadership experience

Innovation Ipsen Global Head Neurotoxins Olivia Brown
PRESS RELEASE

published on 02/21/2025 at 15:42, 1 year 6 months ago

Ipsen S.A. publie ses comptes consolidés 2024
PRESS RELEASE

published on 02/21/2025 at 15:42, 1 year 6 months ago

Ipsen S.A. publishes its 2024 consolidated financial statements
PRESS RELEASE

published on 10/23/2024 at 07:00, 1 year 10 months ago

Ipsen enregistre une forte dynamique commerciale au cours des neuf premiers mois de l'année 2024 et revoit à la hausse ses prévisions pour l'exercice en cours
BRIEF

published on 09/23/2024 at 11:01, 1 year 11 months ago

Franchissement de seuil par Parvus Asset Management dans IPSEN SA

Euronext Paris Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management
BRIEF

published on 09/23/2024 at 11:01, 1 year 11 months ago

Parvus Asset Management crosses threshold in IPSEN SA

Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
PRESS RELEASE

published on 09/23/2024 at 10:56, 1 year 11 months ago

Franchissement de seuil
Déclaration de franchissement de seuil par Parvus Asset Management Europe Limited pour le compte de clients et fonds détenant 7,80% du capital d'IPSEN SA

Droits De Vote Franchissement De Seuil Ipsen SA Parvus Asset Management Cession Actions
BRIEF

published on 09/16/2024 at 14:50, 1 year 11 months ago

Des résultats prometteurs pour Cabometyx dans les tumeurs neuroendocrines avancées

Phase III Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
BRIEF

published on 09/16/2024 at 14:50, 1 year 11 months ago

Promising results for Cabometyx in advanced neuroendocrine tumors

Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
PRESS RELEASE

published on 09/16/2024 at 14:45, 1 year 11 months ago

Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées
Les résultats finaux de l’essai de Phase III CABINET confirment l’efficacité de Cabometyx dans les tumeurs neuroendocrines avancées. Ipsen publie les données au congrès ESMO 2024

Essai Clinique Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx

Accesswire

Published on 09/12/2026 at 02:35, 11 hours 34 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 9 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 4 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 44 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 9 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 6 hours 39 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 54 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 59 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 25 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 54 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE